Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 2, 2011
A live webcast and replay will be available. Read more.
-
Aug 10, 2011
Company also introduces industry's first iPhone®/iPad® app for healthcare professionals using SCS
-
Aug 9, 2011
Company's fully covered metal stent now approved in Canada for use in treating benign biliary strictures
-
Aug 8, 2011
U.S. Court of Appeals for the First Circuit has affirmed the dismissal of a securities fraud case in connection with the 2004 recall of the TAXUS® Express2 Paclitaxel-Eluting Coronary Stent System
-
Aug 8, 2011
Investment supported by grant funding from Government through IDA Ireland
-
Jul 28, 2011
Company also announces new share repurchase, China investment and restructuring program
-
Jul 28, 2011
"This repurchase program reflects our confidence in the strength of the Company's long-term business prospects, earnings growth potential and our ability to generate strong cash flow," said Ray Elliott, President and CEO
-
Jul 27, 2011
Investment to support development of local manufacturing capabilities and training center
-
Jul 21, 2011
Fitch Ratings upgrades Company's corporate credit rating to an investment grade rating, BBB-, with a stable outlook
-
Jul 14, 2011
Boston Scientific will webcast its conference call with financial results and business highlights for Q2 2011 on Thursday, July 28. Learn how to tune in.